The per capita sales of anxiolytic medicine in Germany is forecasted to remain constant at $0.9 from 2024 to 2028. Data for 2023 is necessary to evaluate trends or year-on-year variations. This stable forecast suggests no significant growth or decline in demand or market expansion for anxiolytic medicines through this period.

Future trends to watch for include potential shifts in healthcare policies, changes in societal stress levels post-pandemic, and competitive entrance of alternative therapies. Monitoring these factors will help anticipate market movements that might disrupt the current forecast stability.

Download as XLS

More about Antidepressant Industry 2025-2029